4.6 Article

Probable REM sleep behavior disorder is associated with longitudinal cortical thinning in Parkinson's disease

期刊

NPJ PARKINSONS DISEASE
卷 7, 期 1, 页码 -

出版社

NATURE RESEARCH
DOI: 10.1038/s41531-021-00164-z

关键词

-

资金

  1. Michael J. Fox Foundation for Parkinson's Research
  2. AbbVie
  3. Allergran
  4. Amathus Therapeutics
  5. Avid Radiopharmaceuticals
  6. Biogen
  7. BioLegend
  8. Bristol-Myers Squibb
  9. Celgene
  10. Denali Therapeutics
  11. GE Healthcare
  12. Genentech
  13. GlaxoSmithKline
  14. Golub Capital
  15. Handl Therapeutics
  16. Insitro
  17. Janssen Neuroscience
  18. Eli Lilly and Company
  19. Lundbeck
  20. Merck
  21. Meso Scale Discovery
  22. Pfizer
  23. Piramal
  24. Prevail Therapeutics
  25. Roche
  26. Sanofi Genzyme
  27. Servier
  28. Takeda
  29. Teva Pharmaceuticals
  30. UCB
  31. Verily and Voyager Therapeutics
  32. Tourmaline Chair in Parkinson's disease
  33. Canada Research Chair

向作者/读者索取更多资源

The study found that probable RBD in PD patients is associated with changes in neural structures leading to decreased cognitive performance, and linked with volume decrease in the left caudate nucleus, pallidum, and amygdala.
REM sleep behavior disorder (RBD) has a poor prognostic implication in both motor and non-motor functions in Parkinson's disease (PD) patients. However, to the best of our knowledge no study to date investigated the longitudinal cerebral changes underlying RBD symptoms in PD. We performed the longitudinal study to investigate the association between probable RBD and cortical and subcortical changes in early, de novo PD patients. We studied 78 participants from the Parkinson's Progression Marker Initiative who underwent structural MRI at baseline and after 2 years. The presence of probable RBD (pRBD) was evaluated using the RBD screening questionnaire. We compared the cross-sectional and longitudinal cortical thickness and subcortical volume changes, between PD patients with and without pRBD. At baseline, we found bilateral inferior temporal cortex thinning in the PD-pRBD group compared with the PD-noRBD group. Longitudinally, the PD-pRBD group revealed a significant increase in the rate of thinning in the left insula compared with the PD-noRBD group, and the increased thinning correlated with decreased cognitive performance. In subcortical volume analyses, the presence of pRBD was linked with volume decrease over time in the left caudate nucleus, pallidum and amygdala. The volume changes in the left caudate nucleus revealed correlations with global cognition. These results support the idea that RBD is an important marker of rapid progression in PD motor and non-motor symptoms and suggest that the atrophy in the left insula and caudate nucleus might be the underlying neurobiological mechanisms of the poorer prognosis in PD patients with RBD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据